Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Suspected Heparin-Induced Thrombocytopenia”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Not applicableStudy completedNCT05439265
What this trial is testing

EMR Tool Impact on HIT Documentation and Management

Who this might be right for
HeparinThrombocytopeniaElectronic Health Records
Rush University Medical Center 128
Testing effectiveness (Phase 2)Ended earlyNCT00673439
What this trial is testing

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
University of Louisville 3
Not applicableUnknownNCT06066762
What this trial is testing

Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia.

Who this might be right for
Heparin-induced Thrombocytopenia
Assistance Publique - Hôpitaux de Paris 200
Not applicableLooking for participantsNCT06033300
What this trial is testing

Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia

Who this might be right for
Heparin-induced ThrombocytopeniaHITPlatelet Activation+5 more
Centre Hospitalier Universitaire, Amiens 200
Post-approval studies (Phase 4)Ended earlyNCT00787332
What this trial is testing

A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome

Who this might be right for
Suspected Heparin-Induced Thrombocytopenia
Canyon Pharmaceuticals, Inc. 16
Large-scale testing (Phase 3)Ended earlyNCT01598168
What this trial is testing

Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia

Who this might be right for
Heparin-induced Thrombocytopenia
McMaster University 22
Testing effectiveness (Phase 2)Ended earlyNCT05785819
What this trial is testing

VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

Who this might be right for
Thrombocytopenia, ImmuneHeparin Induced Thrombocytopenia
Veralox Therapeutics 24